Clinical Efficacy for Guselkumab, Long-Term Saftey Profile for Ustekinumab Shown for …

… ulcerative colitis (UC) and CD treated with ustekinumab (Stelara) were presented at Digestive Disease Week meeting in San Diego, California.

Do you trust this headline?

Based on recent headline ratings, 88% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending positive.

88%

Media Trust Score88%